Gingival Hyperplasia Due to Nifedipine Therapy: a case report

Main Article Content

Warin Jongjaroenkamol

Abstract

Abstract: The objective of this report was to review the etiology of gingival hyperplasia. I reported a case of gingival hyperplasia due to long term usage of nifedipine in treatment of hypertension. Upon substitution nifedipine by another antihypertensive drug, the patient’s gingival size reduced. The patient was treated by scaling, root planning, and was instructed to take care of oral hygiene and plaque control, the gingival became normal without any gingival surgery.

Article Details

How to Cite
Jongjaroenkamol, W. (2024). Gingival Hyperplasia Due to Nifedipine Therapy: a case report. Maharat Nakhon Ratchasima Hospital Journal, 26(1), 41–44. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/2155
Section
Case Report

References

Butler RT, Kalkwarf KL, Kaldahl WB. Drug induced gingival hyperplasia: phenytoin, cyclosporin and nifedipine. J Am Dent Assoc 1987;114:55-60.

Lederman D, Lumerman M, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Oral Surg 1984;57:020-2.

Barak S, Engellourg S, Hiss J. Gingival hyplasia cause by nifedipine: histopathologic findings. J Periodontal 1987; 58:639-41.

Angelopoulos AP. Clinicopathological review: diphenylhydantoin gingival hyperplasia II. Aetiology, pathogenesis, differential diagnosis and treatment. J Can Dent Assoc 1975; 41:275-7, 283.

Bezan KT. Gingival enlargement sccondary to nifedipine therapy. Gen Dent 1987;35:353-4.